Mitochondrial Sirt3 Expression is Decreased in APP/PS1 Double Transgenic Mouse Model of Alzheimer’s Disease

Neurochemical Research

Volumn 40, Issue 8, 2015, Pages 1576-1582

  Yang, Wenxiu ^a   Zou, Yan ^b   Zhang, Man ^b   Zhao, Nan ^a   Tian, Qi ^b   Gu, Min ^b   Liu, Wei ^a   Shi, Rui ^b   Lü, Yang ^b   Yu, Weihua ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer s disease; APP PS1 double transgenic mouse; Mitochondrial dysfunction; Sirt3

Indexed keywords

BETA ACTIN; MESSENGER RNA; SIRTUIN 3; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; SIRT3 PROTEIN, MOUSE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MEMORY; MITOCHONDRION; MORRIS WATER MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPATIAL LEARNING; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY;

MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; PRESENILIN-1; SIRTUIN 3;

EID: 84939260692     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1630-1     Document Type: Article

References (32)

1. Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81(2):741–766
2. Mattson MP (2004) Pathways towards and away from Alzheimer’s disease. Nature 430(7000):631–639
3. Swerdlow RH, Burns JM, Khan SM (2014) The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta 1842(8):1219–1231
4. Leuner K, Schütt T, Kurz C et al (2012) Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal 16(12):1421–1433
5. Michan S, Sinclair D (2007) Sirtuins in mammals: insights into their biological function. Biochem J 404(1):1–13
6. Langley B, Sauve A (2013) Sirtuin deacetylases as therapeutic targets in the nervous system. Neurotherapeutics 10(4):605–620
7. Qin W, Yang T, Ho L et al (2006) Neuronal sirt1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281(31):21745–21754
8. Kim D, Nguyen MD, Dobbin MM et al (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. EMBO J 26(13):3169–3179
9. Giralt A, Villarroya F (2012) SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J 444(1):1–10
10. Brenmoehl J, Hoeflich A (2013) Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. Mitochondrial 13(6):755–761
11. Someya S, Yu W, Hallows WC et al (2010) Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143(5):802–812
12. Zou Y, Li Y, Yu W et al (2013) Hypoxia-up-regulated mitochondrial movement regulator does not contribute to the APP/PS1 double transgenic mouse model of Alzheimer’s disease. Dement Geriatr Cogn Disord 36(3–4):137–145
13. Zhong Z, Yang L, Wu X et al (2014) Evidences for B6C3-Tg (APPswe/PSEN1dE9) double-transgenic mice between 3 and 10 months as an age-related Alzheimer’s disease model. J Mol Neurosci 53(3):370–376
14. Glover AR, Zhao JT, Ip JC et al (2015) Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence. Endocr Relat Cancer 22(1):99–109
15. Elman JA, Madison CM, Baker SL, et al (2014) Effects of beta-amyloid on resting state functional connectivity within and between networks reflect known patterns of regional vulnerability. Cereb Cortex. doi:10.1093/cercor/bhu259
16. Xu W, Fitzgerald S, Nixon RA, Levy E, Wilson DA (2015) Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer’s disease. Exp Neurol 264:82–91
17. +-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 21(8):920–928
18. Iwahara T, Bonasio R, Narendra V, Reinberg D (2012) SIRT3 functions in the nucleus in the control of stress-related gene expression. Mol Cell Biol 32(24):5022–5034
19. Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408(6809):239–247
20. Summers DW, DiAntonio A, Milbrandt J (2014) Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons. J Neurosci 9;34(28):9338–9350
21. Lutz MI, Milenkovic I, Regelsberger G, Kovacs GG (2014) Distinct patterns of sirtuin expression during progression of Alzheimer’s disease. Neuromolecular Med 16(2):405–414
22. Parihar P, Solanki I, Mansuri ML, Parihar MS (2015) Mitochondrial sirtuins: emerging roles in metabolic regulations, energy homeostasis and diseases. Exp Gerontol 61C:130–141
23. Hauptmann S, Scherping I, Dröse S et al (2009) Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 30(10):1574–1586
24. Trushina E, Nemutlu E, Zhang S et al (2012) Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer’s disease. PLoS One 7(2):e32737
25. Zeng L, Yang Y, Hu Y et al (2014) Age-related decrease in the mitochondrial sirtuin deacetylase sirt3 expression associated with ROS accumulation in the auditory cortex of the mimetic aging rat model. PLoS One 9(2):e88019
26. Bellizzi D, Rose G, Cavalcante P et al (2005) A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85(2):258–263
27. Ahn BH, Kim HS, Song S et al (2008) A role for the mitochondrial deacetylase sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA 105(38):14447–14452
28. Musatov A, Robinson NC (2012) Susceptibility of mitochondrial electron-transport complexes to oxidative damage. Focus on cytochrome c oxidase. Free Radic Res 46(11):1313–1326
29. Francis BM, Yang J, Song BJ et al (2014) Reduced levels of mitochondrial complex I subunit NDUFB8 and linked complex I + III oxidoreductase activity in the TgCRND8 mouse model of Alzheimer’s disease. J Alzheimers Dis 39(2):347–355
30. 2+ and mitochondrial biogenesis. Int J Mol Sci 15(8):14591–14609
31. Reddy PH, Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease. Trends Mol Med 14(2):45–53
32. Weir HJ, Murray TK, Kehoe PG et al (2012) CNS sirt3 expression is altered by reactive oxygen species and in Alzheimer’s disease. PLoS One 7(11):e48225